Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2023 Earnings Call Transcript May 7, 2023
Operator: Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference call over to Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi.
Naomi Eichenbaum: Thank you. Good afternoon. And welcome to Travere Therapeutics first quarter...
